Heska Corp.

Heska sells veterinary and animal health diagnostic and specialty products. The company's segments are: Core Companion Animal, which includes, primarily for canine and feline use, Point of Care laboratory instruments and consumables, digital imaging diagnostic instruments, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products; and Other Vaccines and Pharmaceuticals, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other species including equine, porcine, avian, feline and canine.
  • TickerHSKA
  • ISINUS42805E3062
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States
MarketLine Department

IDEXX Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report

Summary IDEXX Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights IDEXX Laboratories Inc (IDEXX or 'the company') is engaged in the provision of diagnostics and information technology solutions for animal health, water testing and dairy markets. Its services include consulting, preclinical research, telemedicine, radiology, cardiology and specialt...

MarketLine Department

Virbac Corporation - Strategy, SWOT and Corporate Finance Report

Summary Virbac Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Virbac Corporation (Virbac or 'the company'), a subsidiary of Virbac SA, manufactures and markets animal health and pet care products. The company provides pharmaceutical products in the areas of endo- and ecto-parasiticides, dermatology, dental care, antibiotics, behavioral health, endoc...

MarketLine Department

Sanofi SA - Strategy, SWOT and Corporate Finance Report

Summary Sanofi SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Sanofi SA (Sanofi or 'the group') is a pharmaceutical group that develops, manufactures and markets healthcare products. The group offers a range of products related to rare diseases, multiple sclerosis, oncology, diabetes, and cardiovascular diseases. It also provides prescription products, consu...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

MarketLine Department

Sanofi - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Sanofi Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Sanofi since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Key Highlights This rep...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Examining Prior Extended Periods Despite our concerns regarding the growing performance disparity between the haves (e.g., Technology, FAANG, mega-caps, growth) and the have nots (e.g., Materials, Energy, small-caps, value), the silver lining continues to be that the latter group is not breaking down on an absolute (price) basis. Due to this fact along with several observations highlighted below, we remain bullish. Continue to buy the dips. • Sector Relative Strength Rankings & Weighting Recommendations. Cap-weighted growth Sectors Technology, Services, Discretionary, and Communications co...

Heska Corp: 1 director sold

A director at Heska Corp sold 13,421 shares at 110.278USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board me...

MarketLine Department

IDEXX Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report

Summary IDEXX Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights IDEXX Laboratories Inc (IDEXX or 'the company') is engaged in the provision of diagnostics and information technology solutions for animal health, water testing and dairy markets. Its services include consulting, preclinical research, telemedicine, radiology, cardiology and specialt...

MarketLine Department

Virbac Corporation - Strategy, SWOT and Corporate Finance Report

Summary Virbac Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Virbac Corporation (Virbac or 'the company'), a subsidiary of Virbac SA, manufactures and markets animal health and pet care products. The company provides pharmaceutical products in the areas of endo- and ecto-parasiticides, dermatology, dental care, antibiotics, behavioral health, endoc...

MarketLine Department

Sanofi SA - Strategy, SWOT and Corporate Finance Report

Summary Sanofi SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Sanofi SA (Sanofi or 'the group') is a pharmaceutical group that develops, manufactures and markets healthcare products. The group offers a range of products related to rare diseases, multiple sclerosis, oncology, diabetes, and cardiovascular diseases. It also provides prescription products, consu...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

MarketLine Department

Sanofi - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Sanofi Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Sanofi since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Key Highlights This rep...

Ford Equity US Rating and Forecast Report

Ford Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch